EBGLYSS (lebrikizumab-lbkz) sustained similar levels of skin clearance when administered as a single injection of 250 mg once ...
In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the ...
Guselkumab offers the flexibility of self-administration from the start of treatment in both ulcerative colitis (UC) and Crohn’s disease (CD),1,2,3 providing the simplicity of a fully subcutaneous ...
Nanoscope Therapeutics has released positive 3-year follow-up data from its REMAIN study, the long-term extension of the ...
The Beyem Seyo pack had killed 87 cattle in 7 months in Sierra Valley, and wildlife officials said they exhausted nonlethal ...
Clinical studies have shown that participants using Tirzepatide experienced up to 22% body weight reduction over 72 weeks, ...
This significant financial injection will be delivered through State Biodiversity Boards of Maharashtra and Uttar Pradesh to three Biodiversity Management Committees, viz., Sakharwadi village, Phaltan ...
US domestic manufacturing investment, R&D model shifts, new excipients, and digital traceability are redefining drug ...
An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...
Pakistan’s healthcare landscape has entered a pivotal phase in the management of diabetes and obesity. For years, advanced ...
The company is banking on key new launches, including weight loss drug Semaglutide and biosimilar Abatacept to drive growth ...
Lilly’s upfront offer for Adverum, the developer of a gene therapy for age-related macular degeneration, is less than the ...